Exchange: NASDAQ·Updated 07:50 PM EST

SSII News

News
all
press releases
SS Innovations International (NASDAQ:SSII) Downgraded by Wall Street Zen to "Strong Sell"
Wall Street Zen lowered shares of SS Innovations International from a "sell" rating to a "strong sell" rating in a report on Sunday...
MarketBeat
SS Innovations International (NASDAQ:SSII) Downgraded by Wall Street Zen to "Strong Sell"
Wall Street Zen lowered shares of SS Innovations International from a "sell" rating to a "strong sell" rating in a report on Sunday...
MarketBeat
More News
SS Innovations International (NASDAQ: SSII) announced the successful completion of what it describes as the world’s first dual-console, beating-heart totally endoscopic coronary artery bypass (“TECAB”) surgery utilizing all five arms of its SSi Mantra surgical robotic system. The procedure was performed at Medanta – The Medicity Hospital in Gurugram, India, by Dr. Nitin Kumar Rajput […]
Investor Brand Network
SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced the promotion of Dr. Vishwa Srivastava to president and the appointment of Gary Lo as chief financial officer. Srivastava, who previously served as CEO of the company’s Asia Pacific operations, will focus on building its U.S. business and leading global operations. Both executives […]
Investor Brand Network
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is seeing increased adoption of its SSi Mantra surgical robotic platform, with CEO Dr. Sudhir Srivastava telling The Motley Fool’s interviewer Rachel Warren that the company’s commercial growth reflects a combination of technological capabilities, clinical experience and affordability (https://ibn.fm/EJk05). During the interview, Srivastava […]
Investor Brand Network
SS Innovations (NASDAQ: SSII), a developer of innovative surgical robotic technologies, showcased its surgical robotics platform in a series of remote operations during October medical conferences in Spain and India, including a robotic-assisted cardiac procedure performed by a surgeon approximately 7,500 miles from the patient (https://ibn.fm/EZFDT). The demonstrations featured the company’s SSi Mantra surgical robotic […]
Investor Brand Network
SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were featured in successful telesurgeries during two international medical conferences in October 2026. At the European Association for Cardio-Thoracic Surgery (“EACTS”) Annual Meeting in Barcelona, Spain, Chairman and CEO Dr. Sudhir […]
Investor Brand Network
SSII's rising revenues and robotic surgery adoption signal growth, but widening losses and financing pressures pose challenges to profitability.
Zacks
SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, announced that it submitted its response to a request for additional information from the U.S. Food and Drug Administration (FDA) on Oct. 5, 2026, regarding its 510(k) submission for the SSi Mantra surgical robotic system. The response includes final data from an expanded human […]
Investor Brand Network
SSII and IVDA have sales predominantly in India and Taiwan, respectively.
Zacks
Discover why Zacks initiated coverage of SSII with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how expanding robotic surgery adoption, rising revenues and international growth are offset by persistent losses and regulatory hurdles.
Zacks

Advertisement|Remove ads.